Upcoming Formulation & Delivery Events

Formulation & Delivery UK: In-Person

21 - 22 September 2021 |

London, UK

21 - 22 September 2021

London, UK

+ Digital Day: 23 September 2021 | Online

Learn from and meet leading experts in pharmaceutical science, addressing the critical strategic advances and technical innovation in formulation, drug delivery and drug product development

Formulation & Delivery US: In-Person

01 - 02 February 2022 |

San Diego, USA

01 - 02 February 2022

San Diego, USA

+ Digital Day: 03 February 2022 | Online

Join leaders, experts and researchers at Formulation & Delivery US: In-Person, connecting global pharma, biotech and academia for high-level discussions on the latest innovations for biopharmaceutical development.

Formulation & Delivery UK: In-Person

05 - 06 May 2022 |

London, UK

05 - 06 May 2022

London, UK

Join world-leading experts in drug product development and delivery for this on-site meeting in London. You’ll learn about the latest advancements in the formulation of large and small molecule drugs, new modalities and explore the innovations in the delivery of complex and challenging therapeutics.

More Information Coming Soon

RNA Therapeutics and Delivery US: In-Person

June 2022 |

Boston, USA

June 2022

Boston, USA

Empowering RNA-Based Therapeutics Research, Discovery and Development

More Information Coming Soon

Upcoming Discussion Groups

Our monthly Discussion Groups are hosted by a panel of leading industry experts who explore some of the key issues facing biologics therapeutics today.

Register below to receive a live stream of the discussion as well a complimentary report outlining the key findings and conclusions covered.

Inhaled Biologics

09 November 2021 | 14:00 GMT (UTC+0)

The inhalation industry has recently benefitted from renewed interest in the inhaled administration of biologics. The potential for better respiratory and systemic delivery, as well as increased patient comfort, make the inhaled route an attractive proposition to deliver therapies. Our November discussion group brings together an exclusive panel of key opinion leaders discussing the key factors behind the market’s growth, research priorities, future outlook & how to overcome challenges in this exciting area. 

Part 1: Presentation: History of Inhaled Biologics  

Speaker: David Cipolla, Vice President of Research, Insmed 

Part 2: Discussion: Advancing the Development & Delivery of Inhaled Biologics 

  • Inhaled biologics for respiratory and systemic delivery 
  • Inhaled vaccines 
  • Inhaled monoclonal antibodies 
  • Formulation and devices for inhaled biologics
  • Finding the right therapeutic modality 
  • Infectious diseases 
  • Immunotherapy

Carsten Erdhart, Professor in Pharmaceutics and Biopharmaceutics, Trinity College Dublin 

Francesca Buttini, Associate Professor, University of Parma 
Pavan Muttil, Associate Professor, University of New Mexico 

Small Molecule Formulation and Delivery

Taking place November 2021

Viewer Registration Coming Soon

Reports and write-ups pertaining to previous Discussion Groups are available in our Insights section.

Previous Discussion Groups

Biologics-based medicines are an extremely promising avenue for therapeutics. Given their size, they are extremely sensitive once they enter the gastrointestinal system. For the launch of Oxford Global’s first Formulation & Drug Delivery Discussion Group, we are bringing together thought-leaders discussing the oral delivery of biologics; with an in-depth discussion pertaining to their permeability and bioavailability and explore which drugs are fit to be delivered orally emphasizing the importance of knowing the therapeutic area to target.

Presentation: Oral Delivery Of Biologics – Quo Vadis?  

Speaker: Patrick Garidel, Head of Process, Purification and Pharma Development, Biopharma, Boehringer Ingelheim

Panel Discussion: Oral Delivery of Biologics – Current Challenges & Opportunities

  • Scientific challenges for the oral delivery of biologics
  • Commercial drivers & demand
  • Bioavailability – getting the biologics through the membrane in a sufficient way, including permeability
  • What the future looks like for orally available biologics

Moderator: Patrick Garidel, Head of Process, Purification and Pharma Development, Biopharma, Boehringer Ingelheim


  • Shawn Davies, Head of Drug Delivery, BioPharmaceuticals Development, R&D, AstraZeneca
  • Joel Richard, Chief Technology Officer, Medincell
  • Robert Niiche, Founder & Chief Executive Officer, SmartTab

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Download Series Agenda at a Glance

Submit your details to register your interest & to be kept up to date about relevant services or events. You may opt-out at any time. Please check our Privacy Policy to see how Oxford Global protects and manages your data.

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Formulation & Delivery

Submit your details to receive the monthly newsletter & to be kept up to date about relevant events, monthly discussion groups and portal membership offers. You may opt-out at any time. Please check our Privacy Policy to see how Oxford Global protects and manages your data.